We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Analytical techniques for detecting micro- and nanoplastics in blood and vascular tissues: Strengths and limitations
AI summary Read the abstract
Researchers reviewed analytical techniques for detecting micro- and nanoplastics in blood and vascular tissues, assessing each method's strengths and limitations. The study highlights that human-derived samples pose unique challenges due to limited volumes, high lipid and protein content, and contamination risks, emphasizing the need for standardized protocols to produce reliable data for cardiovascular health research.
Micro- and nanoplastics (MNPs) are increasingly reported in human biofluids and tissues, including cardiovascular-relevant specimens, making reliable detection and quantification a prerequisite for clinically meaningful research in cardiology. However, human-derived matrices are analytically challenging because they are often available in limited amounts, rich in lipids and proteins, highly susceptible to background contamination, and subject to matrix-driven interferences that can bias polymer identification and quantification, particularly for submicron fractions. This review provides a method-focused overview of the analytical toolbox most frequently used for MNPs assessment in biologically relevant and human samples, with specific attention to cardiovascular applications. We compare particle-resolved vibrational approaches (μ-Fourier transform infrared spectroscopy, µ-Raman, and quantum cascade laser-based laser direct infrared spectroscopy) that deliver polymer identification alongside particle counts, size proxies, and morphology, and mass-based strategies (double-shot pyrolysis-gas chromatography/mass spectrometry [MS] and targeted depolymerization coupled to liquid chromatography-MS/MS) that provide polymer-specific mass burdens suited to exposure metrics and clinical correlations. Representative studies are discussed, including recent analyses of atheromatous plaques, coronary blood, thrombi, and other human tissue where polymer burden, morphology, and size have been investigated in relation to adverse health outcomes. Finally, we outline the main advantages and limitations of each technique, emphasizing practical factors that influence data quality and comparability across studies. By framing MNP analytics within clinically relevant cardiovascular specimens and endpoints, this review aims to critically appraise current evidence and design robust translational investigations.
More Papers Like This
Standardizing methodologies to study microplastics and nanoplastics in cardiovascular diseases
AI summary Read the abstract
Researchers highlighted that microplastics and nanoplastics are emerging as new risk factors for cardiovascular health, with evidence indicating they can impair blood vessel cell functions and worsen artery-clogging processes. However, the widely varying concentrations of these particles found in heart and vascular tissues point to a lack of standardized research methods. The study calls for unified approaches to better understand how plastic particles affect the cardiovascular system.
Methods for detecting microplastics in human tissues, with a focus on vascular and intravascular specimens
AI summary Read the abstract
This review summarizes existing research on methods for detecting tiny plastic particles in human tissues, including blood, blood vessels, liver, placenta and heart tissue. It describes the strengths, weaknesses and challenges of different detection techniques, noting that no standard method currently exists for this testing.
Microplastics and Nanoplastics in Human Blood: What the Latest Research Shows
AI summary Read the abstract
A review of recent evidence that micro- and nanoplastics circulate in human blood, drawing on several detection methods. It covers associations with artery plaque and coagulation and examines plasma exchange and blood donation as research questions. Causation remains an open question.
Microplastics and Nanoplastics in Human Blood: Current Evidence, Practical Measurement Limitations, and the Need for Scalable Tests for Public Health Studies and Routine Clinical Use
AI summary Read the abstract
Scientists have confirmed tiny plastic particles (microplastics and nanoplastics) are showing up in human blood, but this review shows that different labs use very different testing methods, making it hard to compare results or track how plastic exposure might affect our health over time. That matters because without a standardized, reliable blood test, we can't yet answer basic questions like how much plastic is in our bodies, whether it's increasing, or what health risks it poses, though the researchers highlight a new testing approach in development that could help solve this problem.
Emerging Analytical Methodologies for Micro- and Nano-Plastics Detection in Human Samples: Analytical Challenges and Health Risk Perspectives
AI summary Read the abstract
Scientists have found tiny plastic particles (microplastics and even smaller nanoplastics) throughout human organs and body fluids, but this review of existing research shows we still lack reliable, standardized tools to accurately measure them—different labs get different results depending on how they prepare and test samples. While lab studies suggest very small plastic particles can cause cell stress and inflammation, there isn't yet solid evidence directly linking plastic exposure to specific diseases in people—so the biggest takeaway is that we urgently need better testing methods before we can truly understand the health risks these particles pose.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.